General ReviewA Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication
Introduction
Intermittent claudication (IC) is the most common symptom of peripheral arterial disease (PAD), affecting 5% of the population over the age of 50 years1 and 20% of the population over 70 years.2 IC is due to muscle ischemia precipitated by exercise and is frequently associated with a reduction in walking capabilities.3 Supervised exercise programs (SEPs) for patients with claudication have been demonstrated to improve walking distances and be cost effective.4 Current clinical guidelines recommend that all patients with IC are enrolled on a group-based SEP.5, 6 Furthermore, centers should consider a program comprised intermittent walking to near maximal or maximal pain, 3 times a week, for a minimum of 12 weeks.7
Although it is agreed that supervised exercise should be the first-line treatment, there is evidence suggesting that relatively few patients are suitable for and will agree to participation in an SEP.8 Many who commence an SEP fail to complete the program of classes. Clearly, the clinical and cost effectiveness of SEPs for managing the population of IC patients as a whole may be significantly affected by poor recruitment and adherence to programs.
This review has 3 aims, first, to establish from the existing literature the levels of uptake of SEPs in published trials, which we defined as the proportion of screened patients who went on to commence an SEP. Second, to determine patient adherence to SEPs, which was defined as the proportion of patients who commenced an SEP and subsequently completed all sessions. Third, to explore what reasons were reported for lack of uptake or adherence in IC patients.
Section snippets
Methods
A systematic review of randomized clinical trial (RCT) and nonrandomized clinical trials including an SEP arm was performed. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for reporting of search results.9
Search Results
The search yielded a total of 333 reports of which 11 were duplicates. Of the remaining 322, 67 were appropriate for inclusion in one or both sections of the planned analysis. The inclusion and/or exclusion process is summarized in Figure 1.
Included Trials
Our analysis included 67 trials, all of which used some form of SEP in claudicants and recorded details of recruited subjects and numbers of those who commenced and completed an SEP. Fifty-two reports were from randomized trials and the remainder were
Discussion
SEPs have been shown to be both clinically and cost effective in treatment of IC, and there is a wealth of evidence supporting the recommendation of SEP as the first-line treatment for IC. However, the results of this review suggest that this evidence may not be universally applicable to the IC population as a whole.
Most trials included in this review gave no indication of numbers of IC patients screened for inclusion which makes the application of their results difficult. Where screening
Conclusions
Details of populations screened, reasons for exclusion, and definitions of adequate uptake and adherence were lacking in most reports. Where data was reported, only 1 in 3 patients screened were suitable for and willing to undertake SEP. This has potential implications for the recommendation of SEP as first-line treatment for all IC patients as there may be a significant proportion of patients where SEP treatment is not accepted or possible. Future reports regarding SEP trials need to include
References (76)
- et al.
A non-randomised controlled trial of the clinical and cost effectiveness of a supervised exercise programme for claudication
Eur J Vasc Endovasc Surg
(2007) - et al.
Diabetes status differentiates endothelial function and plasma nitrite response to exercise stress in peripheral arterial disease following supervised training
J Diabetes Complications
(2014) - et al.
Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial
Eur J Vasc Endovasc Surg
(2004) - et al.
Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study
J Am Coll Cardiol
(2015) - et al.
The influence of a long term exercise program on lower limb movement variability and walking performance in patients with peripheral arterial disease
Hum Mov Sci
(2009) - et al.
A randomised controlled trial of supervised exercise regimens and their impact on walking performance, skeletal muscle mass and calpain activity in patients with intermittent claudication
Eur J Vasc Endovasc Surg
(2014) - et al.
The effect of supervised exercise therapy on physical activity and ambulatory activities in patients with intermittent claudication
Eur J Vasc Endovasc Surg
(2015) - et al.
Optimal exercise program length for patients with claudication
J Vasc Surg
(2012) - et al.
The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication
J Vasc Surg
(2005) - et al.
Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements
Eur J Vasc Endovasc Surg
(2001)
The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial
J Vasc Surg
The effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease
J Cardiol
Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial
Eur J Vasc Endovasc Surg
The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication
Clin Biomech
Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial
J Vasc Interv Radiol
Supervised exercise therapy for intermittent claudication in daily practice
J Vasc Surg
Influence of peripheral arterial disease and supervised walking on heart rate variability
J Vasc Surg
Impact of a supervised strength training or walking training over a subsequent unsupervised therapy period on walking capacity in patients with claudication
J Vasc Nurs
Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication
J Vasc Surg
Exercise training improves functional status in patients with peripheral arterial disease
J Vasc Surg
Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial
Atherosclerosis
Effect of supervised exercise therapy for intermittent claudication in patients with diabetes mellitus
Ann Vasc Surg
Magnetic resonance imaging-based monitoring of collateral artery development in patients with intermittent claudication during supervised exercise therapy
J Vasc Surg
Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication
J Vasc Surg
Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial
J Vasc Surg
Why do health systems not fund supervised exercise programmes for intermittent claudication?
Eur J Vasc Endovasc Surg
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
J Vasc Surg
A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication
Atherosclerosis
Systematic review of home-based exercise programmes for individuals with intermittent claudication
Eur J Vasc Endovasc Surg
Editor's choice–The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis
Eur J Vasc Endovasc Surg
Limb hemodynamics are not predictive of functional capacity in patients with PAD
Vasc Med
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000
Circulation
Intermittent claudication: effective medical management of a common circulatory problem
Am J Cardiol
Exercise for intermittent claudication
Cochrane Database Syst Rev
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication
Cochrane Database Syst Rev
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)–summary of recommendations
J Vasc Interv Radiol
Low attendance of patients with intermittent claudication in a German community-based walking exercise program
Int Angiol
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
BMJ
Cited by (141)
High INtensity Interval Training in pATiEnts with Intermittent Claudication: A Qualitative Acceptability Study
2024, Annals of Vascular SurgeryEditor's Choice – Exercise Therapy for Chronic Symptomatic Peripheral Artery Disease: A Clinical Consensus Document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases in Collaboration With the European Society of Vascular Medicine and the European Society for Vascular Surgery
2024, European Journal of Vascular and Endovascular SurgerySupervised Exercise Therapy for Intermittent Claudication: A Propensity Score Matched Analysis of Retrospective Data on Long Term Cardiovascular Outcomes
2024, European Journal of Vascular and Endovascular SurgeryEditor's Choice – European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication
2024, European Journal of Vascular and Endovascular Surgery
Funding: Miss Harwood is funded by a University of Hull PhD scholarship.